US equities
|
TSLA
$393.11
▲+5.61%
MU
$887.32
▲+1.11%
SPCX
$145.64
▼-1.25%
META
$633.20
▼-1.47%
NVDA
$214.62
▲+1.73%
AAPL
$344.44
▼-0.94%
SNDK
$1,243.88
▲+0.47%
INTC
$87.30
▲+0.39%
TSLA
$393.11
▲+5.61%
MU
$887.32
▲+1.11%
SPCX
$145.64
▼-1.25%
META
$633.20
▼-1.47%
NVDA
$214.62
▲+1.73%
AAPL
$344.44
▼-0.94%
SNDK
$1,243.88
▲+0.47%
INTC
$87.30
▲+0.39%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:GALT
Recent news which mentions NASDAQ:GALT
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
August 13, 2024
Tickers
GALT
Tags
Earnings Reports
Market News
GALT
From
InvestorPlace
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
May 15, 2024
Tickers
GALT
Tags
NASDAQ:GALT
Earnings Reports
GALT
From
InvestorPlace
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
April 05, 2024
Tickers
GALT
Tags
NASDAQ:GALT
Market News
GALT
From
InvestorPlace
Is Galectin Therapeutics a Good Cancer Stock to Own?
July 16, 2021
Tags
NASDAQ:GALT
From
StockNews.com